• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, May 31, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Indiana University researcher-entrepreneur receives $245,000 STTR grant for startup

Bioengineer by Bioengineer
October 9, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Indiana University

BLOOMINGTON, Ind. — A high-tech startup founded by an Indiana University researcher-entrepreneur has been awarded a federal grant to develop technology that aims to reduce the use of animals in chemical toxicity studies of food, pharmaceuticals, pesticides and other products.

Dream Tech LLC has received a one-year STTR Phase I award worth $245,130 from the National Center for Advancing Translational Sciences, or NCATS. Kan Shao, an assistant professor of environmental and occupational health at the IU School of Public Health, founded the company.

"Dream Tech is developing a method to incorporate existing information to enhance the efficiency and effectiveness of dose-response assessment, which addresses a chemical's toxicity. This would reduce animal use in traditional toxicity studies," Shao said. "The project supported by the STTR grant will make this the first system able to integrate useful information. It will significantly advance chemical risk assessment."

Shao said receiving an STTR grant from NCATS, which is part of the National Institutes of Health, is prestigious recognition for Dream Tech.

"Applying for STTR funding is a very rigorous process, especially in meeting the high expectations of NCATS experts as they conduct scientific review and council review," Shao said. "Being awarded one of these ultra-competitive grants reinforces our belief that Dream Tech and its work can help others."

Shao disclosed his innovation to the IU Innovation and Commercialization Office, which protects, markets and licenses intellectual property developed at Indiana University so it can be commercialized by industry. He licensed the innovation and launched Dream Tech to commercialize it.

###

About Indiana University Innovation and Commercialization Office

Indiana University ICO is tasked with the protection and commercialization of technology emanating from innovations by IU researchers. Since 1997, IU research has generated almost 3,200 inventions resulting in more than 4,800 global patent applications. These discoveries have generated more than $145 million in licensing and royalty income, including more than $115 million in funding for IU departments, labs and inventors.

Media Contact

Steve Martin
[email protected]
317-278-1505
@IUScienceNews

http://newsinfo.iu.edu

Original Source

https://news.iu.edu/stories/2018/10/iub/releases/04-dream-tech-receives-sttr-grant.html

Share12Tweet7Share2ShareShareShare1

Related Posts

Impact of Immigration Restrictions on the US Healthcare Workforce

May 31, 2026

Innovative AI Technique Predicts Radiation Dosage Prior to Treatment in Advanced Prostate Cancer

May 31, 2026

COXFA4L2 Boosts Cytochrome C Oxidase in Leigh Syndrome

May 31, 2026

Precise Gene Control Using FDA-Approved RNA Splicing Drug

May 30, 2026
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    319 shares
    Share 128 Tweet 80
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    81 shares
    Share 32 Tweet 20
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    56 shares
    Share 22 Tweet 14
  • AI-Powered Atlas Uncovers Extensive Whole-Body Damage Linked to Obesity

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Impact of Immigration Restrictions on the US Healthcare Workforce

Study Reveals Cancer Diagnostic Delays Linked to Population-Based Screening Using Cell-Free DNA Multicancer Early Detection Test

Innovative AI Technique Predicts Radiation Dosage Prior to Treatment in Advanced Prostate Cancer

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.